Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12611439 | Ionic self-assembling peptides | 🖼🧊📄§ | 2026-04-28 | 2043-02-09 | 0 | 31 |
| 12611458 | Chimeric receptors and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-04-14 | 0 | 31 |
| 12612629 | Duchenne muscular dystrophy-related exonic splicing enhancer, sgRNA and gene editing tool, and applications | 🖼🧊📄§ | 2026-04-28 | 2040-09-30 | 0 | 31 |
| 12612389 | Benzofuran-based N-acylhydrazone derivative and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-04-28 | 2040-07-14 | 0 | 31 |
| 12612627 | Compositions and methods for increasing sodium current in cardiac cells | 🖼🧊📄§ | 2026-04-28 | 2041-04-19 | 0 | 31 |
| 12612457 | Humanized antibodies against Nectin-2 and drug conjugates thereof | 🖼🧊📄§ | 2026-04-28 | 2044-08-28 | 0 | 31 |
| 12611468 | Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma | 🖼🧊📄§ | 2026-04-28 | 2042-02-01 | 0 | 31 |
| 12611395 | Use of carbamate compound for preventing or treating trigeminal neuralgia | 🖼🧊📄§ | 2026-04-28 | 2041-12-02 | 0 | 31 |
| 12611402 | Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency | 🖼🧊📄§ | 2026-04-28 | 2042-06-13 | 0 | 31 |
| 12612612 | Methods for exon skipping and gene knockout using base editors | 🖼🧊📄§ | 2026-04-28 | 2039-07-19 | 0 | 31 |
| 12612453 | Method of treating glomerulonephritis by administering an antibody which binds and neutralizes human TGF-Beta1, TGF-Beta2 and TGF-Beta3 | 🖼🧊📄§ | 2026-04-28 | 2042-09-16 | 0 | 31 |
| 12611394 | Use of ginkgolide a in the treatment of autism | 🖼🧊📄§ | 2026-04-28 | 2040-09-24 | 0 | 31 |
| 12611413 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-04-28 | 2045-07-08 | 0 | 31 |
| 12611430 | Therapeutic agent of peripheral blood flow disorder | 🖼🧊📄§ | 2026-04-28 | 2039-11-29 | 0 | 31 |
| 12611374 | Dermatological collar for non-human animals | 🖼🧊📄§ | 2026-04-28 | 2042-03-09 | 0 | 31 |
| 12612369 | Eco-friendly synthesis of a novel nicotinonitrile derivative (MNPN) with antibacterial and anti-inflammatory activities for preventing pressure ulcers in individuals with disabilities | 🖼🧊📄§ | 2026-04-28 | 2045-12-15 | 0 | 31 |
| 12606618 | Antagonist anti-NPR1 antibodies and methods of use thereof | 🖼🧊📄§ | 2026-04-21 | 2042-12-06 | 0 | 31 |
| 12606523 | Deuterated organic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-07-03 | 0 | 31 |
| 12606555 | Chemical compounds | 🖼🧊📄§ | 2026-04-21 | 2042-04-07 | 0 | 31 |
| 12605418 | Chebulinic acid and its enriched fraction from the fruits of Terminalia chebula for treatment of benign prostatic hyperplasia (BPH) and its preparation thereof | 🖼🧊📄§ | 2026-04-21 | 2041-09-13 | 0 | 31 |
| 12606630 | CD25 chimeric antigen receptors and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-08-28 | 0 | 31 |
| 12605428 | Kinase NEK10 and its use in treating and diagnosing bronchiectasis and other respiratory disorders | 🖼🧊📄§ | 2026-04-21 | 2041-01-19 | 0 | 31 |
| 12605431 | Composition for treating or preventing myopathy, obesity or diabetes | 🖼🧊📄§ | 2026-04-21 | 2041-12-14 | 0 | 31 |
| 12606594 | Heterotandem bicyclic peptide complexes | 🖼🧊📄§ | 2026-04-21 | 2042-02-02 | 0 | 31 |
| 12606822 | Synthetic modified RNA and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-11-06 | 0 | 31 |
| 12605350 | Composition for preventing, ameliorating, or treating disease caused by nitration of tyrosine in proteins comprising tyrosine as effective component | 🖼🧊📄§ | 2026-04-21 | 2041-06-30 | 0 | 31 |
| 12605412 | Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments | 🖼🧊📄§ | 2026-04-21 | 2040-09-29 | 0 | 31 |
| 12605429 | Proteins having pneumococcal capsule degrading activity and methods of use | 🖼🧊📄§ | 2026-04-21 | 2043-05-19 | 0 | 31 |
| 12605363 | Oxymetazoline compositions | 🖼🧊📄§ | 2026-04-21 | 2042-12-23 | 0 | 31 |
| 12606613 | Humanized anti-C5a antibodies | 🖼🧊📄§ | 2026-04-21 | 2041-05-06 | 0 | 31 |
| 12606803 | Methods for growing African swine fever virus in fetal porcine lung alveolar macrophage cells | 🖼🧊📄§ | 2026-04-21 | 2040-07-13 | 0 | 31 |
| 12606828 | Aptamers for use in the treatment of Coronaviridae infections | 🖼🧊📄§ | 2026-04-21 | 2041-04-09 | 0 | 31 |
| 12605456 | Composition and method for HIP1-targeting inhibitor compounds | 🖼🧊📄§ | 2026-04-21 | 2042-05-28 | 0 | 31 |
| 12605390 | Treatment of cancer and inhibition of metastasis | 🖼🧊📄§ | 2026-04-21 | 2041-10-27 | 0 | 31 |
| 12605397 | Deoxy-cytidine or uridine derivatives for use in cancer therapies | 🖼🧊📄§ | 2026-04-21 | 2044-03-12 | 0 | 31 |
| 12606529 | Sulfur and amide tropolone inhibitors of nucleotidyl transferases and uses therefor | 🖼🧊📄§ | 2026-04-21 | 2040-05-03 | 0 | 31 |
| 12605423 | Peptide inhibitors targeting methyltransfer mechanism of SARS-CoV-2 | 🖼🧊📄§ | 2026-04-21 | 2041-09-08 | 0 | 31 |
| 12605354 | Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions | 🖼🧊📄§ | 2026-04-21 | 2041-02-19 | 0 | 31 |
| 12605439 | Universal influenza vaccine compositions | 🖼🧊📄§ | 2026-04-21 | 2041-12-28 | 0 | 31 |
| 12606572 | Substituted heterocycles and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2045-10-07 | 0 | 31 |
| 12606637 | Heparanase-neutralizing A54 monoclonal antibody | 🖼🧊📄§ | 2026-04-21 | 2041-07-06 | 0 | 31 |
| 12605366 | Telmisartan for the treatment of hypertension in dogs | 🖼🧊📄§ | 2026-04-21 | 2040-04-30 | 0 | 31 |
| 12606848 | Globin gene therapy for treating hemoglobinopathies | 🖼🧊📄§ | 2026-04-21 | 2043-07-20 | 0 | 31 |
| 12606597 | Vaccines targeting Pseudomonas aeruginosa | 🖼🧊📄§ | 2026-04-21 | 2043-06-23 | 0 | 31 |
| 12606540 | Triazolone compound | 🖼🧊📄§ | 2026-04-21 | 2041-05-24 | 0 | 31 |
| 12606610 | Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes | 🖼🧊📄§ | 2026-04-21 | 2043-08-16 | 0 | 31 |
| 12605342 | Polymer-encapsulated drug particles | 🖼🧊📄§ | 2026-04-21 | 2044-04-10 | 0 | 31 |
| 12605446 | PSMA-targeted immunotherapies for cancers | 🖼🧊📄§ | 2026-04-21 | 2041-08-20 | 0 | 31 |
| 12606612 | Multivalent DNA antibody constructs and use thereof | 🖼🧊📄§ | 2026-04-21 | 2040-07-31 | 0 | 31 |
| 12605367 | Methods of treatment and/or prevention of disorders and symptoms related to BKCa and/or SK channelophathies | 🖼🧊📄§ | 2026-04-21 | 2040-09-15 | 0 | 31 |